Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Cervical cancer, Secondary cancers
Closed
Phase 2
This trial is looking at whether olaparib and cediranib can improve treatment for cancer of the cervix that has spread or come back.
Cancer Research UK supports this trial.
Recruitment start: 13 September 2018
Recruitment end: 30 November 2022
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Rosemary Lord
Astra Zeneca
Cancer Research UK
Clatterbridge Cancer Centre NHS Foundation Trust
Liverpool Cancer Trials Unit
Last reviewed: 24 June 2024
CRUK internal database number: 15466